Retrospective Comparison of Levofloxacin and Moxifloxacin on Multidrug-Resistant Tuberculosis Treatment Outcomes
Jinwoo Lee, Chang-Hoon Lee, Deog Kyeom Kim, Ho Il Yoon, Jae Yeol Kim, Sang-Min Lee, Seok-Chul Yang, Jae Ho Lee, Chul-Gyu Yoo, Choon-Taek Lee, Hee Soon Chung, Young Whan Kim, Sung Koo Han, Jae-Joon Yim
Korean J Intern Med. 2011;26(2):153-159.   Published online 2011 Jun 1     DOI: https://doi.org/10.3904/kjim.2011.26.2.153
Citations to this article as recorded by Crossref logo
Molecular dynamics simulation and binding free energy studies of novel leads belonging to the benzofuran class inhibitors of Mycobacterium tuberculosis Polyketide Synthase 13
Jorddy N. Cruz, José F. S. Costa, André S. Khayat, Kamil Kuca, Carlos A. L. Barros, A. M. J. C. Neto
Journal of Biomolecular Structure and Dynamics.2019; 37(6): 1616.     CrossRef
Fluoroquinolones in Drug-Resistant Tuberculosis: Culture Conversion and Pharmacokinetic/Pharmacodynamic Target Attainment To Guide Dose Selection
Mohammad H. Al-Shaer, Wael A. Alghamdi, Abdullah Alsultan, Guohua An, Shahriar Ahmed, Yosra Alkabab, Sayera Banu, Ketevan Barbakadze, Eric Houpt, Maia Kipiani, Lali Mikiashvili, J. Peter Cegielski, Russell R. Kempker, Scott K. Heysell, Charles A. Peloquin
Antimicrobial Agents and Chemotherapy.2019;[Epub]     CrossRef
Comparing efficacies of moxifloxacin, levofloxacin and gatifloxacin in tuberculosis granulomas using a multi-scale systems pharmacology approach
Elsje Pienaar, Jansy Sarathy, Brendan Prideaux, Jillian Dietzold, Véronique Dartois, Denise E. Kirschner, Jennifer J. Linderman, Scott L Diamond
PLOS Computational Biology.2017; 13(8): e1005650.     CrossRef
Effect of Extract on Osteoclast Differentiation and Bone-pit Formation
Min-Youn Ahn, Hyung-Ho Lim
Journal of Korean Medicine.2017; 38(3): 59.     CrossRef
An updated systematic review and meta-analysis for treatment of multidrug-resistant tuberculosis
Mayara Lisboa Bastos, Zhiyi Lan, Dick Menzies
European Respiratory Journal.2017; 49(3): 1600803.     CrossRef
SpecificgyrAgene mutations predict poor treatment outcome in MDR-TB
L. Rigouts, N. Coeck, M. Gumusboga, W. B. de Rijk, K. J. M. Aung, M. A. Hossain, K. Fissette, H. L. Rieder, C. J. Meehan, B. C. de Jong, A. Van Deun
Journal of Antimicrobial Chemotherapy.2016; 71(2): 314.     CrossRef
Development and validation of LC-ESI-MS/MS method for analysis of moxifloxacin and levofloxacin in serum of multidrug-resistant tuberculosis patients: Potential application as therapeutic drug monitoring tool in medical diagnosis
Sung Joong Lee, Kebede Taye Desta, Seok Yong Eum, Veronique Dartois, Sang Nae Cho, Dong-Won Bae, Sung Chul Shin
Journal of Chromatography B.2016; 1009-1010: 138.     CrossRef
Impact of Fluoroquinolone Exposure Prior to Tuberculosis Diagnosis on Clinical Outcomes in Immunocompromised Patients
Ju Young Lee, Hyun Jung Lee, Yong Kyun Kim, Shinae Yu, Jiwon Jung, Yong Pil Chong, Sang-Oh Lee, Sang-Ho Choi, Tae Sun Shim, Yang Soo Kim, Jun Hee Woo, Sung-Han Kim
Antimicrobial Agents and Chemotherapy.2016; 60(7): 4005.     CrossRef
Comparative efficacy and acceptability of five anti-tubercular drugs in treatment of multidrug resistant tuberculosis: a network meta-analysis
Huaidong Wang, Xiaotian Zhang, Yuanxiang Bai, Zipeng Duan, Yan Lin, Guoqing Wang, Fan Li
Journal of Clinical Bioinformatics.2015;[Epub]     CrossRef
Diagnosis and Treatment of Multidrug-Resistant Tuberculosis
Tae Sun Shim
Korean Journal of Medicine.2015; 88(5): 509.     CrossRef
Comparison of Levofloxacin versus Moxifloxacin for Multidrug-Resistant Tuberculosis
Won-Jung Koh, Seung Heon Lee, Young Ae Kang, Chang-Hoon Lee, Jae Chol Choi, Jae Ho Lee, Seung Hun Jang, Kwang Ha Yoo, Ki Hwan Jung, Ki Uk Kim, Sang Bong Choi, Yon Ju Ryu, Kyung Chan Kim, Soojung Um, Yong Soo Kwon, Yee Hyung Kim, Won-Il Choi, Kyeongman Jeo
American Journal of Respiratory and Critical Care Medicine.2013; 188(7): 858.     CrossRef
Medical Treatment of Pulmonary Multidrug-Resistant Tuberculosis
Tae Sun Shim, Kyung-Wook Jo
Infection & Chemotherapy.2013; 45(4): 367.     CrossRef
Pseudo-uvéite sévère associée à l’utilisation de moxifloxacine
A. Duncombe, J. Gueudry, N. Massy, C. Chapuzet, I. Gueit, M. Muraine
Journal Français d'Ophtalmologie.2013; 36(2): 146.     CrossRef
Interferon-gamma release assays versus tuberculin skin testing in patients with rheumatoid arthritis
Gwan Gyu Song, Sang-Cheol Bae, Young Ho Lee
International Journal of Rheumatic Diseases.2013; 16(3): 279.     CrossRef
Comparative roles of moxifloxacin and levofloxacin in the treatment of pulmonary multidrug-resistant tuberculosis: a retrospective study
Rui-Hua Jiang, Hong-Bin Xu, Ling Li
International Journal of Antimicrobial Agents.2013; 42(1): 36.     CrossRef
Risk Factors for Poor Treatment Outcomes in Patients with MDR-TB and XDR-TB in China: Retrospective Multi-Center Investigation
Shenjie Tang, Shouyong Tan, Lan Yao, Fujian Li, Li Li, Xinzhi Guo, Yidian Liu, Xiaohui Hao, Yanqiong Li, Xiuxiu Ding, Zhanjun Zhang, Li Tong, Jianan Huang, Katalin Andrea Wilkinson
PLoS ONE.2013; 8(12): e82943.     CrossRef
Fluoroquinolones for treating tuberculosis (presumed drug-sensitive)
Lilia E Ziganshina, Albina F Titarenko, Geraint R Davies
Cochrane Database of Systematic Reviews.2013;[Epub]     CrossRef
New treatment options for multidrug-resistant tuberculosis
Stephen K. Field, Dina Fisher, Julie M. Jarand, Robert L. Cowie
Therapeutic Advances in Respiratory Disease.2012; 6(5): 255.     CrossRef